NSE - Delayed Quote INR

Glenmark Life Sciences Limited (GLS.NS)

Compare
1,045.25 -67.65 (-6.08%)
At close: 3:29 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 5.89B
Earnings 1.11B
?

Analyst Price Targets

790.00 Low
905.75 Average
1,045.25 Current
993.00

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2025)Next Year (2026)
No. of Analysts 1--44
Avg. Estimate 9044.8651.41
Low Estimate 9042.0649.6
High Estimate 9050.855.5
Year Ago EPS 11.9411.0538.3844.86

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2025)Next Year (2026)
No. of Analysts 2--44
Avg. Estimate 5.76B--25.79B29.54B
Low Estimate 5.44B--25.27B29.09B
High Estimate 6.08B--26.58B30B
Year Ago Sales 5.78B--22.83B25.79B
Sales Growth (year/est) -0.40%--12.90%14.60%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 3/31/2024
EPS Est. 9.1210.3211.810.4
EPS Actual 11.9411.059.697.97
Difference 2.820.73-2.11-2.43
Surprise % 30.90%7.10%-17.90%-23.40%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2025)Next Year (2026)
Current Estimate 9044.8651.41
7 Days Ago 9044.8651.41
30 Days Ago 13.28044.8651.41
60 Days Ago 13.28044.8651.41
90 Days Ago 13.28048.3354.05

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD GLS.NSIndustrySectorS&P 500
Current Qtr. -24.60%----3.10%
Next Qtr. ------8.00%
Current Year 16.90%----2.30%
Next Year 14.60%----13.20%
Next 5 Years (per annum) 14.10%----11.85%
Past 5 Years (per annum) --------

Related Tickers